Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL7159292 | 1.00 | LMNA (0.53) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL30900516 | 0.89 | LMNA (0.47) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL28900065 | 0.89 | LMNA (0.47) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL3708808 | 0.85 | LMNA (0.43) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL10780445 | 0.83 | LMNA (0.41) | LMNAALDH1A1OR51E2KDM4EDUSP3 | |
| Glycerin SCHEMBL30929982 | 0.81 | LMNA (0.69) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL7030045 | 0.81 | LMNA (0.69) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL44491 | 0.81 | LMNA (0.69) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL28563108 | 0.81 | LMNA (0.69) | LMNAALDH1A1OR51E2SLC22A6THRB | |
| Glycerin SCHEMBL4671978 | 0.81 | LMNA (0.69) | LMNAALDH1A1OR51E2SLC22A6THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210032495-A1 | WATERBORNE ISOCYANATE-FREE POLYURETHANE EPOXY HYBRID COATINGS | THE UNIVERSITY OF AKRON | 2021-02-04 | — | — | US | claimed |
| US-20110288230-A1 | METHOD FOR PREPARING POLYHYDROXY-URETHANES | RHODIA OPERATIONS (FR) | 2011-11-24 | — | — | US | claimed |
| US-20090312502-A1 | Method for preparing polyhydroxy-urethanes | RHODIA OPERATIONS (FR) | 2009-12-17 | — | — | US | claimed |
| EP-0272664-B1 | CURABLE MIXTURES AND THEIR USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-05-27 | — | — | EP | claimed |
| EP-3375812-B1 | THIO EPOXY RESINS AND METHOD FOR PREPARATION | PERFORMANCE CHEMICALS HANDELS GMBH (DE) | 2024-04-24 | — | — | EP | disclosed |
| US-11932774-B2 | Waterborne isocyanate-free polyurethane epoxy hybrid coatings | THE UNIVERSITY OF AKRON (US) | 2024-03-19 | — | — | US | disclosed |
| CN-116438120-A | Aromatic diol compound, diepoxide compound, polymer prepared from such compound, and process for producing the same | SWIMC有限公司 | 2023-07-14 | — | — | CN | disclosed |
| WO-2022238341-A1 | MELT-MODIFIED THERMOPLASTIC POLYURETHANES AND COMPOSITION COMPRISING THE SAME | Sorbonne Université (FR) | 2022-11-17 | — | — | WO | disclosed |
| EP-4089134-A1 | THERMOPLASTIC POLYURETHANES MODIFIED BY MELTING AND COMPOSITION CONTAINING THEM | Sorbonne Université (FR) | 2022-11-16 | — | — | EP | disclosed |
| US-20210032495-A1 | WATERBORNE ISOCYANATE-FREE POLYURETHANE EPOXY HYBRID COATINGS | THE UNIVERSITY OF AKRON | 2021-02-04 | — | — | US | disclosed |
| CN-107698748-B | Dynamic polymer of hybrid cross-linked network and application thereof | 翁秋梅 | 2020-03-10 | — | — | CN | disclosed |
| CN-106714856-B | Composition containing glycosaminoglycan and protein | 尚卓耐斯特公司 | 2020-03-03 | — | — | CN | disclosed |
| EP-3193952-A1 | COMPOSITION CONTAINING GLYCOSAMINOGLYCANS AND PROTEINS | Chondronest SA (CH) | 2017-07-26 | — | — | EP | disclosed |
| WO-2016042434-A1 | COMPOSITION CONTAINING GLYCOSAMINOGLYCANS AND PROTEINS | SWISSBIOTECH SA (CH) | 2016-03-24 | — | — | WO | disclosed |
| US-9242956-B2 | Method for producing polyglycerol (poly)carbonate | RHODIA OPERATIONS (FR) | 2016-01-26 | — | — | US | disclosed |
| US-20150152079-A1 | Method for producing polyglycerol (poly)carbonate | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2015-06-04 | — | — | US | disclosed |
| US-20110288230-A1 | METHOD FOR PREPARING POLYHYDROXY-URETHANES | RHODIA OPERATIONS (FR) | 2011-11-24 | — | — | US | disclosed |
| US-8017719-B2 | Method for preparing polyhydroxy-urethanes | RHODIA OPERATIONS (FR) | 2011-09-13 | — | — | US | disclosed |
| US-20090312502-A1 | Method for preparing polyhydroxy-urethanes | RHODIA OPERATIONS (FR) | 2009-12-17 | — | — | US | disclosed |
| US-6008314-A | HARDENERS OBTAINED FROM REACTION OF: AMINOURETHANES OBTAINED BY REACTING CYCLIC CARBONATES WITH PRIMARY AMINES; WATER THINNABLE EPOXIDES OBTAINED BY REACTING POLYOXYALKYLENE AMINES WITH EPOXIDES; AND AMINES; FORMING MULTILAYER COATINGS | HERBERTS GMBH (DE) | 1999-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152079-A1 | Method for producing polyglycerol (poly)carbonate | PHOSPHO1, ALG1, AGL | LMNA 974/4885ALDH1A1 4234/4885OR51E2 4499/4885 |
| US-20110288230-A1 | METHOD FOR PREPARING POLYHYDROXY-URETHANES | UROD, HPD, ALKBH3 | LMNA 2578/4885ALDH1A1 2408/4885OR51E2 1501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.